FR2386523A1 - PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT - Google Patents

PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT

Info

Publication number
FR2386523A1
FR2386523A1 FR7810063A FR7810063A FR2386523A1 FR 2386523 A1 FR2386523 A1 FR 2386523A1 FR 7810063 A FR7810063 A FR 7810063A FR 7810063 A FR7810063 A FR 7810063A FR 2386523 A1 FR2386523 A1 FR 2386523A1
Authority
FR
France
Prior art keywords
products containing
medicinal products
prostane derivatives
prostane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7810063A
Other languages
French (fr)
Other versions
FR2386523B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2386523A1 publication Critical patent/FR2386523A1/en
Application granted granted Critical
Publication of FR2386523B1 publication Critical patent/FR2386523B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups

Abstract

Nouveaux dérivés du prostane. Ils répondent à la formule :New derivatives of prostane. They answer the formula:

FR7810063A 1977-04-05 1978-04-05 PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT Granted FR2386523A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772715838 DE2715838A1 (en) 1977-04-05 1977-04-05 NEW PROSTANE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION

Publications (2)

Publication Number Publication Date
FR2386523A1 true FR2386523A1 (en) 1978-11-03
FR2386523B1 FR2386523B1 (en) 1981-02-13

Family

ID=6005974

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7810063A Granted FR2386523A1 (en) 1977-04-05 1978-04-05 PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT

Country Status (11)

Country Link
JP (1) JPS53124238A (en)
BE (1) BE865705A (en)
CH (1) CH638773A5 (en)
DE (1) DE2715838A1 (en)
DK (1) DK150778A (en)
FR (1) FR2386523A1 (en)
GB (1) GB1601994A (en)
IE (1) IE46864B1 (en)
IT (1) IT1093506B (en)
LU (1) LU79369A1 (en)
NL (1) NL7803415A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405943A1 (en) * 1976-11-29 1979-05-11 Merck Patent Gmbh NEW DERIVATIVES OF 13-PROSTENOIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
WO1994006433A1 (en) * 1992-09-21 1994-03-31 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO1994008587A1 (en) * 1992-10-21 1994-04-28 Allergan, Inc. Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6403649B1 (en) 1992-09-21 2002-06-11 Allergan Sales, Inc. Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US8278353B2 (en) 2005-03-16 2012-10-02 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US9801891B2 (en) 2009-12-22 2017-10-31 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066518A1 (en) * 2000-03-09 2001-09-13 Ono Pharmaceutical Co., Ltd. φ-SUBSTITUTED PHENYL-PROSTAGLANDIN E-ALCOHOLS, PROCESS FOR PRODUCING THE SAME AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
US7183310B2 (en) 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7101906B2 (en) * 2004-11-16 2006-09-05 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
US7183324B2 (en) 2004-11-23 2007-02-27 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
EP2628725A1 (en) 2005-11-03 2013-08-21 Allergan, Inc. Prostaglandins and analogues as agents for lowering intraocular pressure

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258845A1 (en) * 1974-01-26 1975-08-22 May & Baker Ltd

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2258845A1 (en) * 1974-01-26 1975-08-22 May & Baker Ltd

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2405943A1 (en) * 1976-11-29 1979-05-11 Merck Patent Gmbh NEW DERIVATIVES OF 13-PROSTENOIC ACID, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
WO1994006433A1 (en) * 1992-09-21 1994-03-31 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5688819A (en) * 1992-09-21 1997-11-18 Allergan Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6403649B1 (en) 1992-09-21 2002-06-11 Allergan Sales, Inc. Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents
WO1994008587A1 (en) * 1992-10-21 1994-04-28 Allergan, Inc. Novel 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amines, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5385945A (en) * 1992-10-21 1995-01-31 Allergan, Inc. 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5552434A (en) * 1992-10-21 1996-09-03 Allergan 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds
US5674910A (en) * 1992-10-21 1997-10-07 Allergan 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
US5773654A (en) * 1992-10-21 1998-06-30 Allergan 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these compounds
US8278353B2 (en) 2005-03-16 2012-10-02 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8299118B2 (en) 2005-03-16 2012-10-30 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8309605B2 (en) 2005-03-16 2012-11-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8338479B2 (en) 2005-03-16 2012-12-25 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8524777B2 (en) 2005-03-16 2013-09-03 Allergan Inc. Enhanced bimatoprost ophthalmic solution
US8586630B2 (en) 2005-03-16 2013-11-19 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8772338B2 (en) 2005-03-16 2014-07-08 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933120B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US8933127B2 (en) 2005-03-16 2015-01-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9155716B2 (en) 2005-03-16 2015-10-13 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US9801891B2 (en) 2009-12-22 2017-10-31 Allergan, Inc. Compositions and methods for lowering intraocular pressure

Also Published As

Publication number Publication date
IT1093506B (en) 1985-07-19
NL7803415A (en) 1978-10-09
IE780671L (en) 1978-10-05
GB1601994A (en) 1981-11-04
IE46864B1 (en) 1983-10-19
JPS53124238A (en) 1978-10-30
BE865705A (en) 1978-10-05
FR2386523B1 (en) 1981-02-13
DK150778A (en) 1978-10-06
CH638773A5 (en) 1983-10-14
DE2715838A1 (en) 1978-10-19
IT7821951A0 (en) 1978-04-04
LU79369A1 (en) 1978-07-13

Similar Documents

Publication Publication Date Title
FR2398741A1 (en) PROSTAGLANDIN I2 DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
FR2387220A1 (en) BENZIMIDAZOLE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
FR2370755A1 (en) STEROIDIC SPIROLACTONS AND MEDICINAL PRODUCTS CONTAINING IT
FR2364210A1 (en) HETEROCYCLIC PHENYL ETHERS AND HERBICIDAL PRODUCTS CONTAINING THEM
FR2415616A1 (en) PHENYLACETIC ACID DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
FR2433512A1 (en) INDANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING SAME
FR2370731A1 (en) NEW DERIVATIVES OF PIPERIDINE POLYSUBSTITUES, THEIR METHODS OF PREPARATION AND THEIR PHARMACEUTICAL APPLICATION
FR2386523A1 (en) PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
FR2414504A1 (en) OXADIAZOLES-1,2,4 AND HERBICIDE PRODUCTS CONTAINING IT
FR2312240A1 (en) PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
FR2398053A1 (en) BIS-CARBAMATES AND HERBICIDAL PRODUCTS CONTAINING IT
FR2395993A1 (en) TRIPLE 18-BOND PROSTANE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
FR2378772A1 (en) THIAZOLYL-CINNAMONITRILES AND PESTICIDE PRODUCTS WHICH CONTAIN IT
FR2366312A1 (en) CORTICOSTEROIDS AND MEDICINAL PRODUCTS CONTAINING THEM
FR2370082A1 (en) MONO-AZOIC PIGMENTS AND THEIR PREPARATION
FR2355021A1 (en) NEW DERIVATIVES OF IMIDAZOTHIAZINE AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2378026A1 (en) MEDICINAL PRODUCTS CONTAINING DERIVATIVES OF HYDROXYMETHYL-2-AMINO-2'-DIPHENYL SULFIDE
FR2426674A1 (en) CYCLOHEXENE-1,2-DICARBOXAMIDES AND HERBICIDE COMPOSITIONS CONTAINING THEM
FR2361361A1 (en) NEW DERIVATIVES OF CYCLOPENTANE AND MEDICINAL PRODUCTS CONTAINING THESE SUBSTANCES
FR2393031A1 (en) MONOAZOIC PIGMENTS AND THEIR PREPARATION
FR2356636A1 (en) PROSTANOIC ACID DERIVATIVES AND MEDICINAL PRODUCTS WHICH CONTAIN IT
FR2366313A1 (en) PREDNISOLONE 9-CHLORO DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING IT
FR2355830A1 (en) NEW DERIVATIVES OF 6-7-BENZOMORPHANE, THEIR OBTAINING AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
FR2415107A1 (en) 5-PHENETHYL-2-OXAZOLIDONE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
FR2428649A1 (en) DIESTERS IN 17,21 OF HYDROCORTISONE AND MEDICINAL PRODUCTS CONTAINING SAME

Legal Events

Date Code Title Description
ST Notification of lapse